Article
Bu‑Shen‑Ning‑Xin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4+ T lymphocytes of ovariectomized mice.
International journal of molecular medicine - 1 Jul 2018
Zhang Jia-Li, Qiu Xue-Min, Zhang Na, Tang Wei, Gober Hans-Jürgen, Li Da-Jin, Wang Ling
Abstract excerpt
Postmenopausal osteoporosis (PMO) has been recognized as an inflammatory condition. CD4+ T cells serve a key role in the interaction between bone metabolism and the immune system. Bu‑Shen‑Ning‑Xin decoction (BSNXD), a traditional Chinese medicine, has been ultilized as a remedy for PMO. In the present study, the aim was to investigate the immune modulatory effects of BSNXD on CD4+ T cells, receptor activation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
